Zyon Ayni’s Code Pharma on ynet TV

Zyon Ayni - ynet

Codivir, an antiviral medication against COVID-19, was developed by Code Pharma and its Founder and CEO, Zyon Ayni. Dr. Einat Finkelstein, Chief Scientist of the company, appeared on the ynet studio, talking about the development of the medicine, which is intended for severe patients: “We have worked with patients in Africa and we have seen great … Read more

“Code Pharma playing an Important Role in the Race to Develop a Cure for COVID-19”

Zyon Ayni - IssueWire

Zyon Ayni, CEO and Founder of Code Pharma, said on IssueWire: “The entire team of Code Pharma is very excited today. We are a company of people playing an important role in the race to develop a cure for COVID-19. Our drug Codivir, was first discovered at the Hebrew University in Israel and it has … Read more

Zyon Ayni: “Potentially – a Breakthrough in the Field of Antiviral Therapy” | Yahoo

Zyon Ayni - Yahoo

Zyon Ayni, CEO and founder of Code Pharma, told Yahoo Finance about the intention to launch an Initial Public Offering (IPO) and the limited fundraising round: “Today is a very exciting day for the Code Pharma team. We are well positioned to play a key role in the current race to develop a cure for … Read more

The Citizen: Code Pharma is Developing an Antiviral Drug Against Covid-19

Zyon Ayni - The Citizen

The Citizen published an article about Code Pharma, a Dutch pharmaceutical company developing a direct antiviral drug against Covid-19. Codivir, a 16-amino-acid synthetic peptide derived from HIV-1 integrase, was first discovered at Hebrew University in Israel. The peptide had a direct antiviral effect against the novel coronavirus Covid-19. “We have seen good results with the … Read more